G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 12,946 | 10,250 | 23,576 | 10,573 | 6,902 |
| Cost of Goods | 1,459 | 992 | 1,111 | 976 | 669 |
| Gross Profit | 11,487 | 9,258 | 22,465 | 9,597 | 6,233 |
| Operating Expenses | 37,692 | 41,137 | 44,124 | 47,535 | 53,683 |
| Operating Income | -25,746 | -30,887 | -21,548 | -36,962 | -46,781 |
| Interest Expense | 3,089 | 2,996 | 2,764 | 2,407 | 2,265 |
| Other Income | 1,240 | 715 | 259 | -77 | -146 |
| Pre-tax Income | -27,595 | -33,168 | -24,053 | -39,446 | -49,192 |
| Income Tax | N/A | 481 | 1,219 | 0 | N/A |
| Net Income Continuous | -27,595 | -33,649 | -25,272 | -39,446 | -49,192 |
| Net Income | $-27,595 | $-33,649 | $-25,272 | $-39,446 | $-49,192 |
| EPS Basic Total Ops | -0.53 | -0.72 | -0.59 | -0.92 | -1.15 |
| EPS Basic Continuous Ops | -0.53 | -0.72 | -0.59 | -0.92 | -1.15 |
| EPS Diluted Total Ops | -0.53 | -0.72 | -0.59 | -0.92 | -1.15 |
| EPS Diluted Continuous Ops | -0.53 | -0.72 | -0.59 | -0.92 | -1.15 |
| EPS Diluted Before Non-Recurring Items | -0.53 | -0.73 | -0.59 | N/A | N/A |
| EBITDA(a) | $-25,073 | $-30,207 | $-20,803 | $-36,280 | $-46,125 |